Cathie Wood’s Redhill Biopharma RDHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,045
Closed -$1.17M 314
2022
Q2
$1.17M Buy
1,045
+183
+21% +$251K 0.01% 232
2022
Q1
$2.17M Buy
+862
New +$2.04M 0.01% 218
2021
Q4
Sell
-19
Closed -$88K 368
2021
Q3
$88K Sell
19
-768
-98% -$5.21M ﹤0.01% 293
2021
Q2
$5.42M Buy
787
+11
+1% +$75.9K 0.01% 220
2021
Q1
$5.68M Buy
776
+609
+365% +$5.11M 0.01% 209
2020
Q4
$1.35M Buy
167
+44
+36% +$396K ﹤0.01% 202
2020
Q3
$1.26M Sell
123
-23
-16% -$189K 0.01% 144
2020
Q2
$979K Buy
146
+50
+52% +$344K 0.01% 162
2020
Q1
$436K Buy
96
+38
+66% +$190K 0.01% 138
2019
Q4
$354K Buy
58
+2
+4% +$12.8K 0.01% 172
2019
Q3
$393K Sell
56
-4
-7% -$29.1K 0.01% 167
2019
Q2
$389K Sell
60
-6
-9% -$46.2K 0.01% 160
2019
Q1
$548K Buy
66
+5
+8% +$39.6K 0.02% 119
2018
Q4
$337K Buy
61
+12
+24% +$91.9K 0.01% 140
2018
Q3
$434K Sell
49
-64
-57% -$521K 0.01% 153
2018
Q2
$961K Buy
113
+9
+9% +$57.2K 0.04% 104
2018
Q1
$534K Buy
104
+75
+259% +$432K 0.03% 130
2017
Q4
$149K Buy
+29
New +$195K 0.01% 159

Other funds holding RDHL

Cathie Wood's RDHL Position: Q3 2022 in Review

Cathie Wood sold out of Redhill Biopharma (RDHL) in Q3 2022, closing a stake of 1,045 shares — an estimated $1.17M sold.

Cathie Wood first reported a position in RDHL in Q4 2017 and held it in 18 quarters. The position peaked at $5.68M in Q1 2021. 40 funds tracked by Wall St. Rank hold RDHL as of Q3 2022.

  • Cathie Wood reported no remaining Redhill Biopharma position as of Q3 2022 after selling out during the quarter.
  • Cathie Wood sold 1,045 Redhill Biopharma shares in Q3 2022, an estimated $1.17M.
  • Cathie Wood first reported a position in Redhill Biopharma in Q4 2017 and held it in 18 quarters.
  • Cathie Wood's Redhill Biopharma position peaked at $5.68M in Q1 2021.
  • 40 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2022.

Based on ARK Investment Management's 13F filing for Q3 2022, filed 17 Oct 2022.